Online financial quotes, charts and technical
analysis for stock and commodity traders.
| MERCK & CO INC - Fundamental Profile|| |
| Company Information |
| Ticker Symbol:
| Contact Info:
|| ONE MERCK DRIVE P.O. BOX 100
WHITEHOUSE STATION NJ 08889-0100
|| KENNETH C. FRAZIER
|SIC: 2834, Large Cap Pharma
|| Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.
| Share Information |
| Market Value, $K:
|| Shares Outstanding, K:
| % Held by Insiders:
|| % Institutional Shareholders:
| Last Quarter Sales, $M:
|| Last Quarter Net Income, $M:
| Last Quarter EPS:
|| P/E Ratio:
| Annual EPS, $:
|| Most Recent Earnings, $:
|| 0.88 on 02/05/14
| Annual Dividend Rate, $:
|| Most Recent Dividend:
|| 0.440 on 12/12/13
| Annual Dividend Yield, %:
|| Most Recent Split:
|| 2-1 on 02/17/99
Fundamental information provided by Zacks Investment Research, Inc.
Zacks does not represent, warrant,
or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever
to any party on account of any incompleteness of, inaccuracies in or untimeliness of the Zacks content provided
hereunder, or for any delay in reporting such data. Zacks expressly disclaims all warranties of fitness of the
Zacks content or computations and analyses thereof for a particular purpose or use.|
|All Equities data is delayed according to exchange rules. Futures data is end of day.
NYSE, AMEX and Nasdaq at least 15 minutes.